Galenic formulations of aliskiren

The present invention relates to a dosage form for transmucosal administration comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, nd an excipient for transmucosal delivery, wherein the active ingredient is present in an amount of 0.001 to 80% by...

Full description

Saved in:
Bibliographic Details
Main Author BEGONA CARRENO-GOMEZ
Format Patent
LanguageEnglish
Published 03.02.2011
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a dosage form for transmucosal administration comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, nd an excipient for transmucosal delivery, wherein the active ingredient is present in an amount of 0.001 to 80% by weight based on the total weight of the dosage form.
Bibliography:Application Number: AU20070287549